Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1982-1-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0144-2945
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6117599-Chlorpheniramine,
pubmed-meshheading:6117599-Drug Therapy, Combination,
pubmed-meshheading:6117599-Histamine H1 Antagonists,
pubmed-meshheading:6117599-Humans,
pubmed-meshheading:6117599-Nylidrin,
pubmed-meshheading:6117599-Tinnitus,
pubmed-meshheading:6117599-Vasodilator Agents
|
pubmed:year |
1981
|
pubmed:articleTitle |
Vasodilator-antihistamine therapy and tinnitus control.
|
pubmed:publicationType |
Journal Article
|